(Reuters) - Shares of Vivus Inc rose nearly 88 percent on Thursday as investors bet that its experimental weight-loss drug, Qnexa, would be approved by U.S. regulators.
Source: http://feeds.reuters.com/~r/reuters/globalmarketsNews/~3/5BnllvlTtXg/us-vivus-shares-idUSTRE81M0ZU20120223
domestic news summit news sports news make money online money save money
No comments:
Post a Comment